cytarabine has been researched along with Liver Failure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergua, J; Carpio, C; Herrera, P; Martínez-Cuadrón, D; Montesinos, P; Moscardó, F; Oriol, A; Rodríguez-Veiga, R; Salamero, O; Sanz, J; Sanz, MA; Vidriales, B; Vives, S | 1 |
| Chen, J; Gu, L; Liu, Y; Pan, C; Tang, J; Xue, H | 1 |
| Hidaka, T; Koga, H; Miyako, K; Suga, N; Takahashi, N | 1 |
| Fujisawa, S; Fujita, H; Kanamori, H; Koharazawa, H; Matsuzaki, M; Mishima, A; Mohri, H; Murata, T; Tanaka, M; Yamaji, S | 1 |
1 trial(s) available for cytarabine and Liver Failure
| Article | Year |
|---|---|
Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia.
Topics: Adenine Nucleotides; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Comorbidity; Cytarabine; Drug Eruptions; Female; Humans; Leukemia, Myeloid, Acute; Liver Failure; Male; Mucositis; Prospective Studies; Remission Induction | 2014 |
3 other study(ies) available for cytarabine and Liver Failure
| Article | Year |
|---|---|
Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Clinical Chemistry Tests; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Female; Harringtonines; Hematologic Tests; Hepatitis B; Homoharringtonine; Humans; Infant; Leukemia, Myeloid, Acute; Liver Failure; Male; Pancreatitis; Remission Induction; Secondary Prevention | 2011 |
Improving circulatory disturbance in transient abnormal myelopoiesis.
Topics: Antimetabolites, Antineoplastic; Blood Transfusion; Cytarabine; Down Syndrome; Fatal Outcome; GATA1 Transcription Factor; Humans; Hypertension, Pulmonary; Infant, Newborn; Infant, Newborn, Diseases; Liver Failure; Male; Mutation; Myelopoiesis; Renal Insufficiency | 2012 |
Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome.
Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Cytarabine; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Liver Failure; Middle Aged; Myelodysplastic Syndromes | 1999 |